NCT00568412

A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

A Multicenter, Randomized, Double-blind Clinical Study to Examine the Efficacy and Safety of Zarzenda in Comparison to Elidel in the Management of Mild to Moderate Atopic Dermatitis in Children and Adolescents

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 2 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

To show therapeutic efficacy of Zarzenda cream compared to Elidel cream in children and adolescents with mild to moderate atopic dermatitis

Conditions

• Mild to Moderate Atopic Dermatitis

Interventions

Type	Name	Description
DEVICE	Zarzenda	Topical cream, applied twice daily for three weeks
DRUG	Elidel	1% cream, applied topically twice daily for three weeks

Timeline

• Start date: 2007-12-01
• Primary completion: 2008-09-01
• Completion: 2008-09-01
• First posted: 2007-12-06
• Last updated: 2015-02-18

Locations

1 site across 1 country: Germany